Loading…
100 years of modelling ligand–receptor binding and response: A focus on GPCRs
Experimental pharmacologists rely on the application of models to describe biological observations in order to learn about a drug's effective concentration, the strength with which it binds its target and drives a response (at either molecular or system level), and the nature of more complex dr...
Saved in:
Published in: | British journal of pharmacology 2020-04, Vol.177 (7), p.1472-1484 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4438-6cb876c3d990f3bf6be8ad2a609080a65190e28605171070cf4f86e18a0358cf3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4438-6cb876c3d990f3bf6be8ad2a609080a65190e28605171070cf4f86e18a0358cf3 |
container_end_page | 1484 |
container_issue | 7 |
container_start_page | 1472 |
container_title | British journal of pharmacology |
container_volume | 177 |
creator | Finlay, David B. Duffull, Stephen B. Glass, Michelle |
description | Experimental pharmacologists rely on the application of models to describe biological observations in order to learn about a drug's effective concentration, the strength with which it binds its target and drives a response (at either molecular or system level), and the nature of more complex drug actions (allosterism/functional selectivity). Models in current use build upon decades of basic principles, going back to the beginning of the last century. Yet often, researchers are only partially familiar with these underlying principles, creating the potential for confusion due to failure to recognise the underpinning assumptions of the models that are used. Here, we describe the history of receptor theory as it underpins receptor stimulus–response models in use today, emphasising particularly attributes and models relevant to GPCRs—and point to some current aims of model development. |
doi_str_mv | 10.1111/bph.14988 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7060363</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2372461503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4438-6cb876c3d990f3bf6be8ad2a609080a65190e28605171070cf4f86e18a0358cf3</originalsourceid><addsrcrecordid>eNp1kMFKAzEURYMoWqsLf0ACrlyMvjQzScaFoEVbQbCIrkMmk7Qj08mYtEp3_oN_6JeY2iq6MJtA7sl5j4vQAYETEs9p0U5OSJoLsYE6JOUsyaggm6gDADwhRIgdtBvCE0AMebaNdijJeZYR0UF3BAAvjPIBO4unrjR1XTVjXFdj1ZQfb-_eaNPOnMdF1ZTLJD5jb0LrmmDO8AW2Ts_j5wYPRv37sIe2rKqD2V_fXfR4ffXQHya3d4Ob_sVtotOUioTpQnCmaZnnYGlhWWGEKnuKQQ4CFMtIDqYnGGSEE-CgbWoFM0QooJnQlnbR-crbzoupKbVpZl7VsvXVVPmFdKqSf5Ommsixe5EcGFBGo-BoLfDueW7CTD65uW_izrJHeS9lJIMldbyitHcheGN_JhCQy-5l7F5-dR_Zw98r_ZDfZUfgdAW8VrVZ_G-Sl6PhSvkJiriNtg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2372461503</pqid></control><display><type>article</type><title>100 years of modelling ligand–receptor binding and response: A focus on GPCRs</title><source>Wiley</source><source>PubMed Central</source><creator>Finlay, David B. ; Duffull, Stephen B. ; Glass, Michelle</creator><creatorcontrib>Finlay, David B. ; Duffull, Stephen B. ; Glass, Michelle</creatorcontrib><description>Experimental pharmacologists rely on the application of models to describe biological observations in order to learn about a drug's effective concentration, the strength with which it binds its target and drives a response (at either molecular or system level), and the nature of more complex drug actions (allosterism/functional selectivity). Models in current use build upon decades of basic principles, going back to the beginning of the last century. Yet often, researchers are only partially familiar with these underlying principles, creating the potential for confusion due to failure to recognise the underpinning assumptions of the models that are used. Here, we describe the history of receptor theory as it underpins receptor stimulus–response models in use today, emphasising particularly attributes and models relevant to GPCRs—and point to some current aims of model development.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/bph.14988</identifier><identifier>PMID: 31975518</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Ligands ; Protein Binding ; Receptors, G-Protein-Coupled - metabolism ; Review</subject><ispartof>British journal of pharmacology, 2020-04, Vol.177 (7), p.1472-1484</ispartof><rights>2020 The British Pharmacological Society</rights><rights>2020 The British Pharmacological Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4438-6cb876c3d990f3bf6be8ad2a609080a65190e28605171070cf4f86e18a0358cf3</citedby><cites>FETCH-LOGICAL-c4438-6cb876c3d990f3bf6be8ad2a609080a65190e28605171070cf4f86e18a0358cf3</cites><orcidid>0000-0002-6545-9408 ; 0000-0002-5997-6898 ; 0000-0002-3160-2931</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060363/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060363/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31975518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Finlay, David B.</creatorcontrib><creatorcontrib>Duffull, Stephen B.</creatorcontrib><creatorcontrib>Glass, Michelle</creatorcontrib><title>100 years of modelling ligand–receptor binding and response: A focus on GPCRs</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>Experimental pharmacologists rely on the application of models to describe biological observations in order to learn about a drug's effective concentration, the strength with which it binds its target and drives a response (at either molecular or system level), and the nature of more complex drug actions (allosterism/functional selectivity). Models in current use build upon decades of basic principles, going back to the beginning of the last century. Yet often, researchers are only partially familiar with these underlying principles, creating the potential for confusion due to failure to recognise the underpinning assumptions of the models that are used. Here, we describe the history of receptor theory as it underpins receptor stimulus–response models in use today, emphasising particularly attributes and models relevant to GPCRs—and point to some current aims of model development.</description><subject>Ligands</subject><subject>Protein Binding</subject><subject>Receptors, G-Protein-Coupled - metabolism</subject><subject>Review</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kMFKAzEURYMoWqsLf0ACrlyMvjQzScaFoEVbQbCIrkMmk7Qj08mYtEp3_oN_6JeY2iq6MJtA7sl5j4vQAYETEs9p0U5OSJoLsYE6JOUsyaggm6gDADwhRIgdtBvCE0AMebaNdijJeZYR0UF3BAAvjPIBO4unrjR1XTVjXFdj1ZQfb-_eaNPOnMdF1ZTLJD5jb0LrmmDO8AW2Ts_j5wYPRv37sIe2rKqD2V_fXfR4ffXQHya3d4Ob_sVtotOUioTpQnCmaZnnYGlhWWGEKnuKQQ4CFMtIDqYnGGSEE-CgbWoFM0QooJnQlnbR-crbzoupKbVpZl7VsvXVVPmFdKqSf5Ommsixe5EcGFBGo-BoLfDueW7CTD65uW_izrJHeS9lJIMldbyitHcheGN_JhCQy-5l7F5-dR_Zw98r_ZDfZUfgdAW8VrVZ_G-Sl6PhSvkJiriNtg</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Finlay, David B.</creator><creator>Duffull, Stephen B.</creator><creator>Glass, Michelle</creator><general>Blackwell Publishing Ltd</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6545-9408</orcidid><orcidid>https://orcid.org/0000-0002-5997-6898</orcidid><orcidid>https://orcid.org/0000-0002-3160-2931</orcidid></search><sort><creationdate>202004</creationdate><title>100 years of modelling ligand–receptor binding and response: A focus on GPCRs</title><author>Finlay, David B. ; Duffull, Stephen B. ; Glass, Michelle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4438-6cb876c3d990f3bf6be8ad2a609080a65190e28605171070cf4f86e18a0358cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Ligands</topic><topic>Protein Binding</topic><topic>Receptors, G-Protein-Coupled - metabolism</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Finlay, David B.</creatorcontrib><creatorcontrib>Duffull, Stephen B.</creatorcontrib><creatorcontrib>Glass, Michelle</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Finlay, David B.</au><au>Duffull, Stephen B.</au><au>Glass, Michelle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>100 years of modelling ligand–receptor binding and response: A focus on GPCRs</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2020-04</date><risdate>2020</risdate><volume>177</volume><issue>7</issue><spage>1472</spage><epage>1484</epage><pages>1472-1484</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>Experimental pharmacologists rely on the application of models to describe biological observations in order to learn about a drug's effective concentration, the strength with which it binds its target and drives a response (at either molecular or system level), and the nature of more complex drug actions (allosterism/functional selectivity). Models in current use build upon decades of basic principles, going back to the beginning of the last century. Yet often, researchers are only partially familiar with these underlying principles, creating the potential for confusion due to failure to recognise the underpinning assumptions of the models that are used. Here, we describe the history of receptor theory as it underpins receptor stimulus–response models in use today, emphasising particularly attributes and models relevant to GPCRs—and point to some current aims of model development.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>31975518</pmid><doi>10.1111/bph.14988</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-6545-9408</orcidid><orcidid>https://orcid.org/0000-0002-5997-6898</orcidid><orcidid>https://orcid.org/0000-0002-3160-2931</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 2020-04, Vol.177 (7), p.1472-1484 |
issn | 0007-1188 1476-5381 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7060363 |
source | Wiley; PubMed Central |
subjects | Ligands Protein Binding Receptors, G-Protein-Coupled - metabolism Review |
title | 100 years of modelling ligand–receptor binding and response: A focus on GPCRs |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A20%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=100%20years%20of%20modelling%20ligand%E2%80%93receptor%20binding%20and%20response:%20A%20focus%20on%20GPCRs&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Finlay,%20David%20B.&rft.date=2020-04&rft.volume=177&rft.issue=7&rft.spage=1472&rft.epage=1484&rft.pages=1472-1484&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/bph.14988&rft_dat=%3Cproquest_pubme%3E2372461503%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4438-6cb876c3d990f3bf6be8ad2a609080a65190e28605171070cf4f86e18a0358cf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2372461503&rft_id=info:pmid/31975518&rfr_iscdi=true |